On May 28th, Hubei Medical Insurance Bureau and Provincial Health and Health Commission jointly issued the Notice on Further Reducing the Price of Nucleic Acid Testing Projects in novel coronavirus. According to the requirements of the notice, starting from May 30th, the price of single inspection of nucleic acid detection in public medical institutions in the province will be reduced from 24 yuan to 16 yuan, and the price of mixed inspection will remain unchanged at 4 yuan per person. The price of antigen testing dropped to 2 yuan per person; The price of antigen testing and the total charge of antigen testing reagents shall be reduced to no more than 6 yuan per person. The above-mentioned government-guided prices for nucleic acid detection and antigen detection are the highest, and the actual charging standards of public medical institutions shall not fluctuate.
Updated on May 9, 2022.
According to the requirements of the notice, from May 10, public medical institutions in the whole province will reduce the price of single-person nucleic acid testing to 24 yuan every time, and the price of mixed testing to 4 yuan every time. This price is the highest guidance price, and fluctuation is not allowed.
Adjusted on April 3, 2022
On April 2nd, Hubei Medical Insurance Bureau and Provincial Health and Wellness Committee issued a notice on further reducing the price of nucleic acid testing items in novel coronavirus.
According to the requirements of the Notice, starting from April 3rd, the price of single nucleic acid testing in public medical institutions in the province will be reduced to 28 yuan each time, and the price of mixed testing will be reduced to 8 yuan per person. The price is guided by the government and is not allowed to fluctuate up and down.
Updated on 20211124th.
Since 20021and1.25, Hubei Province has reduced the price of COVID-19 nucleic acid testing items in public medical institutions, regardless of the level of medical institutions, reducing the price of single-person single testing to 40 yuan each time, and the price of 10 mixed testing and 5 mixed testing to each person 10 yuan.
The previous price was:
In order to further improve the prevention and control of epidemic situation and nucleic acid detection in COVID-19, the Provincial Medical Insurance Bureau and the Provincial Health and Health Commission jointly issued the Notice on Adjusting the Price of Nucleic Acid Detection Projects in novel coronavirus. The maximum price of novel coronavirus nucleic acid testing project in public medical institutions is adjusted from 80 yuan to 60 yuan every time, and a mixed testing project is set up. The maximum price of mixed testing of public medical institutions 10 people is per person 15 yuan, which was implemented in the whole province on August 9.
Updated on 202 1 1 15.
In order to implement the spirit of the redeployment meeting of the provincial prevention and control headquarters for the prevention and control of normalized epidemic situation, further improve the accurate prevention and control of normalized epidemic situation, and effectively protect people's life safety and health, recently, the Provincial Medical Insurance Bureau and the Provincial Health and Health Commission jointly issued the Notice on Re-adjusting the price of testing items in novel coronavirus. The price of the project was adjusted from 132 yuan for each person's nucleic acid test to 80 yuan, and from 40 yuan for each person's antibody test to in June 5438+1October 6544 in 25 yuan.
In this price adjustment, the Provincial Medical Insurance Bureau and the Provincial Health and Health Commission jointly carried out the operating cost survey and price survey of medical institutions, and combined with the fact that the reagent testing technology is mature, the market competition is full, and the daily testing volume in our province is large, the price of testing items was appropriately adjusted on the basis of considering the technical service value of medical personnel.
At the same time, all public medical institutions are required to provide services and collect fees for patients in strict accordance with regulations, standardize their own price behaviors, update and maintain information systems and publicize prices in a timely manner, and consciously accept social supervision.